FBRX
USDForte Biosciences Inc. Common Stock
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$12.580
Kõrge
$12.580
Madal
$11.610
Maht
0.01M
Ettevõtte fundamentaalnäitajad
Turukapitalisatsioon
148.2M
Tööstusharu
Biotehnoloogia
Riik
United States
Kauplemisstatistika
Keskmine maht
0.09M
Börs
NCM
Valuuta
USD
52 nädala vahemik
Seotud uudised
Forte Biosciences Announces Pricing of $75 Million Public Offering
Forte Biosciences, Inc. (NASDAQ:FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, today announced the pricing of a public offering of 5,630,450 shares of its common
Forte Biosciences Announces Proposed Public Offering
Forte Biosciences, Inc. (NASDAQ:FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, today announced that it has commenced an underwritten public offering of shares of
Chardan Capital Maintains Buy on Forte Biosciences, Maintains $61 Price Target
Chardan Capital analyst Daniil Gataulin maintains Forte Biosciences with a Buy and maintains $61 price target.
Forte Biosciences Announces Positive Data in FB102 Celiac Disease Phase 1B Study
Phase 2 Celiac Disease Trial Initiating with Topline Readout Expected in 2026 Forte will be Hosting a Conference Call to Discuss the Results at 8:30 am ET Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ:FBRX),
Seotud aktsiad
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.